Fennec Pharmaceuticals FENC
NASDAQ FENC
$12.39 -0.16 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fennec Pharmaceuticals (FENC) EPS (Diluted) (2010 - 2026)

Analysis

Fennec Pharmaceuticals (FENC) EPS (Diluted) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.23
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.15
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.15
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Fennec Pharmaceuticals 432.85 Mn 391.60 Mn 17.15 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Dec 31, 2025 -0.09
Sep 30, 2025 -0.02
Jun 30, 2025 -0.11
Mar 31, 2025 -0.04
Dec 31, 2024 -0.05
Sep 30, 2024 -0.21
Jun 30, 2024 -0.20
Mar 31, 2024 0.42
Dec 31, 2023 -0.10
Sep 30, 2023 -0.07
Jun 30, 2023 -0.20
Mar 31, 2023 -0.22
Dec 31, 2022 -0.26
Sep 30, 2022 -0.31
Jun 30, 2022 -0.19
Mar 31, 2022 -0.14
Dec 31, 2021 -0.16
Sep 30, 2021 -0.16
Jun 30, 2021 -0.15